Lv41
600 积分 2023-08-28 加入
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
1小时前
已完结
Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
2天前
已完结
The Distinction between 'Glucose Setpoint�, 'Glucose Threshold� and 'Glucose Sensor� is Critical for Understanding the Role of the Pancreatic β-Cell in Glucose Homeostasis
7天前
已完结
葡萄糖激酶激活剂：调控细胞内葡萄糖代谢的第一步
11天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
21天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
21天前
已完结
Evaluation of Insulin Dosage After the Addition of Tirzepatide Compared With Semaglutide or Dulaglutide in Patients With Type 2 Diabetes
30天前
已完结
2型糖尿病患者C肽评估胰岛β细胞功能随病程变化的分析
1个月前
已完结
成人阻塞性睡眠呼吸暂停诊治指南计划书
1个月前
已完结
皖公网安备34019202002308
